LAUSR

Botulinum Toxin Therapy of Social Anxiety Disorder: A Case Series.

Sign Up to like & get
recommendations!
1 Published in 2019 at "Journal of Clinical Psychopharmacology"

DOI: 10.1097/jcp.0000000000001066

Abstract: DISCUSSION Guanfacine may suppress rapid eye movement sleep, modulate sleep architecture, and can result in less sleepwalking. As a selective α-adrenergic 2A agonist, it has the ability to regulate glutamatergic and catecholamine systems, both implicated… read more here.

Keywords: guanfacine; toxin therapy; case; therapy social ... See more keywords